Both in Pharmaceuticals
Tango Therapeutics vs Amylyx Pharmaceuticals
Over the past year TNGX returned +187.7% and AMLX returned +106.5%; their daily moves had a correlation of 0.22.
TNGX +187.7% AMLX +106.5%Growth of $1, one year, split-adjusted
| Metric | TNGX | AMLX |
|---|---|---|
| Price | $22.53 | $28.68 |
| Market cap | $3.80B | $3.60B |
| Today | +1.35% | +2.17% |
| 1 month | −9.7% | −1.4% |
| 6 months | +4.2% | +79.3% |
| Year to date | +154.3% | +137.4% |
| 1 year | +189.2% | +100.3% |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 70.6× | — |
| Net cash | $1.01B | $250.8M |
| Dividend yield | — | — |
| Volatility (60d) | 72.9% | 114.5% |
| Short % of float | 31.9% | 13.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).